| 1 | [SID103648919] | Active | IC50 | 19 | Inhibition of 2-oxoglutarate-dependent human recombinant HIF PHD2 preincubated for 1 hr [AID344926, Type: Literature] | Egl nine homolog 1 [gi:32129514] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Active | | IC50 | 19 [uM] | | BioAssay | Inhibition of 2-oxoglutarate-dependent human recombinant HIF PHD2 preincubated for 1 hr | | AID | 344926 | | BioAssay type | Literature | | Target | Egl nine homolog 1 [gi:32129514] | | PubMed | 18942826 | | Data Table |  |
|
| 2 | [SID103648919] | Active | IC50 | 19.09 | Destabilizing effect on human recombinant PHD2 (181-426) expressed in Escherichia coli BL21 (DE3) assessed as half life by limited trypsinolysis/MALDI-MS analysis in presence of ferrous ion [AID349748, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Active | | IC50 | 19.09 [uM] | | BioAssay | Destabilizing effect on human recombinant PHD2 (181-426) expressed in Escherichia coli BL21 (DE3) assessed as half life by limited trypsinolysis/MALDI-MS analysis in presence of ferrous ion | | AID | 349748 | | BioAssay type | Literature | | Target | | | PubMed | 19364117 | | Data Table |  |
|
| 3 | [SID103648919] | Active | | | Inhibition of human recombinant carbonic anhydrase 5B by stopped flow CO2 hydration method [AID456400, Type: Literature] | Carbonic anhydrase 5B, mitochondrial [gi:8928041] |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Active | | BioAssay | Inhibition of human recombinant carbonic anhydrase 5B by stopped flow CO2 hydration method | | AID | 456400 | | BioAssay type | Literature | | Target | Carbonic anhydrase 5B, mitochondrial [gi:8928041] | | PubMed | 19962903 | | Data Table |  |
|
| 4 | [SID103648919] | Active | | | Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydration method [AID456397, Type: Literature] | Carbonic anhydrase 2 [gi:115456] |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Active | | BioAssay | Inhibition of human recombinant carbonic anhydrase 2 by stopped flow CO2 hydration method | | AID | 456397 | | BioAssay type | Literature | | Target | Carbonic anhydrase 2 [gi:115456] | | PubMed | 19962903 | | Data Table |  |
|
| 5 | [SID103648919] | Active | | | Inhibition of human recombinant carbonic anhydrase 5A by stopped flow CO2 hydration method [AID456399, Type: Literature] | Carbonic anhydrase 5A, mitochondrial [gi:461680] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Active | | BioAssay | Inhibition of human recombinant carbonic anhydrase 5A by stopped flow CO2 hydration method | | AID | 456399 | | BioAssay type | Literature | | Target | Carbonic anhydrase 5A, mitochondrial [gi:461680] | | PubMed | 19962903 | | Data Table |  |
|
| 6 | [SID103648919] | Unspecified | Ki | 616.595 | Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr [AID360150, Type: Literature] | Solute carrier family 22 member 6 [gi:81901833] |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | Ki | 616.595 [uM] | | BioAssay | Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr | | AID | 360150 | | BioAssay type | Literature | | Target | Solute carrier family 22 member 6 [gi:81901833] | | PubMed | 17553798 | | Data Table |  |
|
| 7 | [SID103648919] | Unspecified | IC50 | 1600 | Inhibition of 2-oxoglutarate-dependent human JMJD2E in prescence of excess H3K9me3 peptide and 10 uM Fe2 by FDH coupled assay [AID344917, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | IC50 | 1600 [uM] | | BioAssay | Inhibition of 2-oxoglutarate-dependent human JMJD2E in prescence of excess H3K9me3 peptide and 10 uM Fe2 by FDH coupled assay | | AID | 344917 | | BioAssay type | Literature | | Target | | | PubMed | 18942826 | | Data Table |  |
|
| 8 | [SID103648919] | Unspecified | IC50 | 2300 | Inhibition of 2-oxoglutarate-dependent human JMJD2E preincubated for 30 mins by FDH coupled assay [AID344918, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | IC50 | 2300 [uM] | | BioAssay | Inhibition of 2-oxoglutarate-dependent human JMJD2E preincubated for 30 mins by FDH coupled assay | | AID | 344918 | | BioAssay type | Literature | | Target | | | PubMed | 18942826 | | Data Table |  |
|
| 9 | [SID103648919] | Unspecified | IC50 | 10000 | Inhibition of 2-oxoglutarate-dependent human JMJD2E in presence of excess 2-oxoglutarate and 10 uM Fe2 by FDH coupled assay [AID344916, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | IC50 | 10000 [uM] | | BioAssay | Inhibition of 2-oxoglutarate-dependent human JMJD2E in presence of excess 2-oxoglutarate and 10 uM Fe2 by FDH coupled assay | | AID | 344916 | | BioAssay type | Literature | | Target | | | PubMed | 18942826 | | Data Table |  |
|
| 10 | [SID103648919] | Unspecified | Ki | 31622.8 | Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr [AID360149, Type: Literature] | Solute carrier family 22 member 20 [gi:56404586] |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | Ki | 31622.8 [uM] | | BioAssay | Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr | | AID | 360149 | | BioAssay type | Literature | | Target | Solute carrier family 22 member 20 [gi:56404586] | | PubMed | 17553798 | | Data Table |  |
|
| 11 | [SID103648919] | Unspecified | | | Displacement of [3H]nicotinic acid from human GPR109a receptor expressed in human HEK293T cells at 10 uM by liquid scintillation counting [AID594382, Type: Literature] | Hydroxycarboxylic acid receptor 2 [gi:74762622] |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | BioAssay | Displacement of [3H]nicotinic acid from human GPR109a receptor expressed in human HEK293T cells at 10 uM by liquid scintillation counting | | AID | 594382 | | BioAssay type | Literature | | Target | Hydroxycarboxylic acid receptor 2 [gi:74762622] | | PubMed | 21167710 | | Data Table |  |
|
| 12 | [SID103648919] | Unspecified | | | Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydration method [AID456398, Type: Literature] | Carbonic anhydrase 1 [gi:115449] |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant carbonic anhydrase 1 by stopped flow CO2 hydration method | | AID | 456398 | | BioAssay type | Literature | | Target | Carbonic anhydrase 1 [gi:115449] | | PubMed | 19962903 | | Data Table |  |
|
| 13 | [SID103648919] | Unspecified | | | Activation of human recombinant wild type mitochondrial NADP-ME expressed in Escherichia coli BL21 assessed as one-half maximal activation by spectrophotometry [AID429168, Type: Literature] | NADP-dependent malic enzyme, mitochondrial [gi:215274021] |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | BioAssay | Activation of human recombinant wild type mitochondrial NADP-ME expressed in Escherichia coli BL21 assessed as one-half maximal activation by spectrophotometry | | AID | 429168 | | BioAssay type | Literature | | Target | NADP-dependent malic enzyme, mitochondrial [gi:215274021] | | PubMed | 19595601 | | Data Table |  |
|
| 14 | [SID85148759] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 15 | [SID85148759] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 16 | [SID103648919] | Unspecified | | | Inhibition of human recombinant PHD2 (181-426) expressed in Escherichia coli BL21 (DE3) by TR-FRET assay [AID349747, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | BioAssay | Inhibition of human recombinant PHD2 (181-426) expressed in Escherichia coli BL21 (DE3) by TR-FRET assay | | AID | 349747 | | BioAssay type | Literature | | Target | | | PubMed | 19364117 | | Data Table |  |
|
| 17 | [SID103648919] | Unspecified | | | Selectivity ratio of Kinact for human recombinant carbonic anhydrase 1 to Kinact for human recombinant carbonic anhydrase 5A [AID456401, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | BioAssay | Selectivity ratio of Kinact for human recombinant carbonic anhydrase 1 to Kinact for human recombinant carbonic anhydrase 5A | | AID | 456401 | | BioAssay type | Literature | | Target | | | PubMed | 19962903 | | Data Table |  |
|
| 18 | [SID103648919] | Unspecified | | | Selectivity ratio of Kinact for human recombinant carbonic anhydrase 2 to Kinact for human recombinant carbonic anhydrase 5A [AID456402, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | BioAssay | Selectivity ratio of Kinact for human recombinant carbonic anhydrase 2 to Kinact for human recombinant carbonic anhydrase 5A | | AID | 456402 | | BioAssay type | Literature | | Target | | | PubMed | 19962903 | | Data Table |  |
|
| 19 | [SID103648919] | Unspecified | | | Selectivity ratio of Kinact for human recombinant carbonic anhydrase 1 to Kinact for human recombinant carbonic anhydrase 5B [AID456403, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | BioAssay | Selectivity ratio of Kinact for human recombinant carbonic anhydrase 1 to Kinact for human recombinant carbonic anhydrase 5B | | AID | 456403 | | BioAssay type | Literature | | Target | | | PubMed | 19962903 | | Data Table |  |
|
| 20 | [SID103648919] | Unspecified | | | Selectivity ratio of Kinact for human recombinant carbonic anhydrase 2 to Kinact for human recombinant carbonic anhydrase 5B [AID456404, Type: Literature] | |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | BioAssay | Selectivity ratio of Kinact for human recombinant carbonic anhydrase 2 to Kinact for human recombinant carbonic anhydrase 5B | | AID | 456404 | | BioAssay type | Literature | | Target | | | PubMed | 19962903 | | Data Table |  |
|
| 21 | [SID17389670] | Unspecified | | | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways [AID651838, Type: other] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17389670 | | CID | 444972 | | Outcome | Unspecified | | BioAssay | qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways | | AID | 651838 | | BioAssay type | other | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID103648919] | Unspecified | | | Ratio of pKi for mouse Oat1 expressed in Xenopus oocytes to pKi for mouse Oat6 expressed in Xenopus oocytes [AID360151, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103648919 | | CID | 444972 | | Outcome | Unspecified | | BioAssay | Ratio of pKi for mouse Oat1 expressed in Xenopus oocytes to pKi for mouse Oat6 expressed in Xenopus oocytes | | AID | 360151 | | BioAssay type | Literature | | Target | | | PubMed | 17553798 | | Data Table |  |
|
| 23 | [SID85148759] | Inactive | Potency | 0.92 | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. [AID624297, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | Potency | 0.92 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. | | AID | 624297 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 24 | [SID85148759] | Inactive | Potency | 3.1623 | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails [AID540317, Type: confirmatory] | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | Potency | 3.1623 [uM] | | BioAssay | HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails | | AID | 540317 | | BioAssay type | confirmatory | | Target | chromobox protein homolog 1 [Homo sapiens] [gi:187960037] | | PubMed | | | Data Table |  |
|
| 25 | [SID17389670] | Inactive | Potency | 3.9811 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17389670 | | CID | 444972 | | Outcome | Inactive | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 26 | [SID17389670] | Inactive | Potency | 3.9811 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17389670 | | CID | 444972 | | Outcome | Inactive | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 27 | [SID17389670] | Inactive | Potency | 3.9811 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17389670 | | CID | 444972 | | Outcome | Inactive | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 28 | [SID85148759] | Inactive | | | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID485273, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | BioAssay | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 485273 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 29 | [SID85148759] | Inactive | | | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay [AID485273, Type: screening] | UBE2N gene product [Homo sapiens] [gi:4507793] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | BioAssay | uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay | | AID | 485273 | | BioAssay type | screening | | Target | UBE2N gene product [Homo sapiens] [gi:4507793] | | PubMed | | | Data Table |  |
|
| 30 | [SID85148759] | Inactive | | | uHTS identification of SUMO1-mediated protein-protein interactions [AID602429, Type: screening] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | BioAssay | uHTS identification of SUMO1-mediated protein-protein interactions | | AID | 602429 | | BioAssay type | screening | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 31 | [SID85148759] | Inactive | Potency | | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 32 | [SID85148759] | Inactive | Potency | | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 33 | [SID85148759] | Inactive | Potency | | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 34 | [SID85148759] | Inactive | Potency | | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 35 | [SID17389670] | Inactive | Potency | | qHTS assay for small molecule antagonists of vitamin D receptor signaling [AID588541, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17389670 | | CID | 444972 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of vitamin D receptor signaling | | AID | 588541 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table |  |
|
| 36 | [SID17389670] | Inactive | Potency | | qHTS assay for small molecule antagonists of vitamin D receptor signaling [AID588541, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17389670 | | CID | 444972 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of vitamin D receptor signaling | | AID | 588541 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table |  |
|
| 37 | [SID17389670] | Inactive | Potency | | qHTS assay for small molecule antagonists of vitamin D receptor signaling [AID588541, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17389670 | | CID | 444972 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of vitamin D receptor signaling | | AID | 588541 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table |  |
|
| 38 | [SID17389670] | Inactive | Potency | | qHTS assay for small molecule antagonists of vitamin D receptor signaling [AID588541, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17389670 | | CID | 444972 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule antagonists of vitamin D receptor signaling | | AID | 588541 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table |  |
|
| 39 | [SID17389670] | Inactive | Potency | | qHTS assay for small molecule agonists of vitamin D receptor signaling [AID588543, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17389670 | | CID | 444972 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of vitamin D receptor signaling | | AID | 588543 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table |  |
|
| 40 | [SID17389670] | Inactive | Potency | | qHTS assay for small molecule agonists of vitamin D receptor signaling [AID588543, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17389670 | | CID | 444972 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of vitamin D receptor signaling | | AID | 588543 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table |  |
|
| 41 | [SID17389670] | Inactive | Potency | | qHTS assay for small molecule agonists of vitamin D receptor signaling [AID588543, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17389670 | | CID | 444972 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of vitamin D receptor signaling | | AID | 588543 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table |  |
|
| 42 | [SID17389670] | Inactive | Potency | | qHTS assay for small molecule agonists of vitamin D receptor signaling [AID588543, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17389670 | | CID | 444972 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay for small molecule agonists of vitamin D receptor signaling | | AID | 588543 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table |  |
|
| 43 | [SID85148759] | Inactive | Potency | | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 44 | [SID85148759] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 45 | [SID85148759] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 46 | [SID85148759] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) [AID588352, Type: screening] | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3) | | AID | 588352 | | BioAssay type | screening | | Target | nuclear receptor coactivator 3 isoform a [Homo sapiens] [gi:32307126] | | PubMed | | | Data Table |  |
|
| 47 | [SID85148759] | Inactive | | | Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity [AID602329, Type: screening] | RAD54L gene product [Homo sapiens] [gi:216548193] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | BioAssay | Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 602329 | | BioAssay type | screening | | Target | RAD54L gene product [Homo sapiens] [gi:216548193] | | PubMed | | | Data Table |  |
|
| 48 | [SID85148759] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 49 | [SID85148759] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) [AID651719, Type: screening] | GALR3 gene product [Homo sapiens] [gi:4503907] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3) | | AID | 651719 | | BioAssay type | screening | | Target | GALR3 gene product [Homo sapiens] [gi:4503907] | | PubMed | | | Data Table |  |
|
| 50 | [SID85148759] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) [AID588354, Type: screening] | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 85148759 | | CID | 444972 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1) | | AID | 588354 | | BioAssay type | screening | | Target | nuclear receptor coactivator 1 isoform 1 [Homo sapiens] [gi:22538455] | | PubMed | | | Data Table |  |
|